NXThera

Medical Devices & EquipmentSeries CMaple Grove, USnxthera.com

Latest round

Series C

Last raised

Feb 2014

Total raised

$33M

Investors

7

About NXThera

Founded in 2008 and based in Minnesota, US, NXThera, Inc. develops medical devices for the treatment of benign prostatic hyperplasia, prostate cancer and kidney cancer.

Who invested in NXThera

7 investors across 6 rounds

See all investors in NXThera

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Feb 21, 2014

    Amount

    $5.9M

    Investors

    Locked

  2. Series C

    Jul 30, 2013

    Amount

    $6.6M

    Investors

    Locked

  3. Series B

    Aug 31, 2011

    Amount

    $2M

    Investors

    Locked

  4. Series B

    Mar 16, 2011

    Amount

    $13M

    Investors

    Locked

  5. Series A

    Nov 16, 2009

    Amount

    $3M

    Investors

    Locked

  6. Series A

    May 8, 2008

    Amount

    $3.2M

    Investors

    Locked

Questions about NXThera

Who invested in NXThera?

NXThera has 7 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has NXThera raised?

NXThera has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did NXThera last raise money?

NXThera's most recent round on record is a Series C, in Feb 2014.

What does NXThera do?

Founded in 2008 and based in Minnesota, US, NXThera, Inc.

Where is NXThera headquartered?

NXThera is headquartered in Maple Grove, US.

Which VCs invest in companies like NXThera?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at NXThera's stage. Their profiles are linked below.

Raising like NXThera? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.